Point72 Asset Management’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.4M Buy
1,007,016
+295,391
+42% +$7.89M 0.04% 635
2025
Q4
$19.7M Buy
711,625
+192,244
+37% +$4.63M 0.02% 904
2025
Q3
$13M Buy
519,381
+481,769
+1,281% +$10.7M 0.02% 704
2025
Q2
$662K Sell
37,612
-14,962
-28% -$241K ﹤0.01% 1696
2025
Q1
$825K Buy
52,574
+44,653
+564% +$753K ﹤0.01% 1493
2024
Q4
$152K Buy
+7,921
New +$163K ﹤0.01% 1929

Other funds holding PHVS

Point72 Asset Management's PHVS Position: Q1 2026 in Review

Point72 Asset Management increased its Pharvaris (PHVS) stake by 42% in Q1 2026, buying an estimated $7.89M and bringing the position to 1,007,016 shares worth $28.4M. The position accounts for 0.04% of the portfolio, ranked #635.

Point72 Asset Management first reported a position in PHVS in Q4 2024 and has held it in 6 quarters since. 110 funds tracked by Wall St. Rank hold PHVS as of Q1 2026.

  • Point72 Asset Management held 1,007,016 shares of Pharvaris worth $28.4M as of Q1 2026.
  • Point72 Asset Management bought 295,391 Pharvaris shares in Q1 2026, an estimated $7.89M.
  • Pharvaris made up 0.04% of Point72 Asset Management's portfolio in Q1 2026, its #635 holding.
  • Point72 Asset Management first reported a position in Pharvaris in Q4 2024 and has held it in 6 quarters since.
  • 110 funds tracked by Wall St. Rank held Pharvaris as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.